{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:07:28Z","timestamp":1778803648672,"version":"3.51.4"},"reference-count":101,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["NRF-2017R1A6A1A030515713"],"award-info":[{"award-number":["NRF-2017R1A6A1A030515713"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002511","name":"Konyang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002511","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jiac.2026.102908","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T16:12:10Z","timestamp":1768320730000},"page":"102908","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Adjunctive and supportive strategies to mitigate drug toxicities in the treatment of nontuberculous mycobacterial disease with future directions"],"prefix":"10.1016","volume":"32","author":[{"given":"Ho Won","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoe Sun","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jake","family":"Whang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0998-5569","authenticated-orcid":false,"given":"Jong-Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2026.102908_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9112262","article-title":"3rd. Ecology of nontuberculous mycobacteria","volume":"9","author":"Falkinham","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.jiac.2026.102908_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jctube.2021.100244","article-title":"Approach to the diagnosis and treatment of non-tuberculous mycobacterial disease","volume":"24","author":"Pennington","year":"2021","journal-title":"Journal of clinical tuberculosis and other mycobacterial diseases"},{"key":"10.1016\/j.jiac.2026.102908_bib3","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ccm.2023.08.012","article-title":"Global epidemiology of nontuberculous mycobacterial pulmonary disease: a review","volume":"44","author":"Prevots","year":"2023","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.jiac.2026.102908_bib4","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3201\/eid2206.151086","article-title":"Epidemiology of pulmonary nontuberculous mycobacterial disease, Japan","volume":"22","author":"Namkoong","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jiac.2026.102908_bib5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3389\/fimmu.2020.00303","article-title":"The rise of non-tuberculosis mycobacterial lung disease","volume":"11","author":"Ratnatunga","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jiac.2026.102908_bib6","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000023775","article-title":"Incidence of nontuberculous mycobacterial disease and coinfection with tuberculosis in a tuberculosis-endemic region: a population-based retrospective cohort study","volume":"99","author":"Lin","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.jiac.2026.102908_bib7","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12890-019-0982-8","article-title":"Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease","volume":"19","author":"Kim","year":"2019","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jiac.2026.102908_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/biom10091210","article-title":"Alpha-lactalbumin, amazing calcium-binding protein","volume":"10","author":"Permyakov","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.jiac.2026.102908_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01640-23","article-title":"Treatment outcomes and relapse in patients with Mycobacterium avium-intracellulare complex pulmonary disease","volume":"11","author":"Chang","year":"2023","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jiac.2026.102908_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01274-25","article-title":"Culture conversion and macrolide resistance in Mycobacterium abscessus complex pulmonary disease","author":"Chen","year":"2025","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jiac.2026.102908_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1394220","article-title":"Treatment for non-tuberculous mycobacteria: challenges and prospects","volume":"15","author":"Conyers","year":"2024","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jiac.2026.102908_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20235868","article-title":"Mycobacterium abscessus, an emerging and worrisome pathogen among cystic fibrosis patients","volume":"20","author":"Degiacomi","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jiac.2026.102908_bib13","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1093\/jac\/dku007","article-title":"Erm(41)-dependent inducible resistance to azithromycin and clarithromycin in clinical isolates of Mycobacterium abscessus","volume":"69","author":"Maurer","year":"2014","journal-title":"The Journal of antimicrobial chemotherapy"},{"key":"10.1016\/j.jiac.2026.102908_bib14","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00535-2020","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ats\/ers\/escmid\/idsa clinical practice guideline","volume":"56","author":"Daley","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2026.102908_bib15","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1164\/rccm.201807-1318OC","article-title":"Amikacin liposome inhalation suspension for treatment-refractory lung disease caused by mycobacterium avium complex (convert). A prospective, open-label, randomized study","volume":"198","author":"Griffith","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2026.102908_bib16","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2017-210927","article-title":"British thoracic society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (Ntm-pd)","volume":"72","author":"Haworth","year":"2017","journal-title":"Thorax"},{"key":"10.1016\/j.jiac.2026.102908_bib17","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1128\/JCM.02950-14","article-title":"Utility of sequencing the erm(41) gene in isolates of Mycobacterium abscessus subsp. abscessus with low and intermediate clarithromycin mics","volume":"53","author":"Brown-Elliott","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jiac.2026.102908_bib18","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01991-2018","article-title":"Mycobacterium abscessus pulmonary disease: individual patient data meta-analysis","volume":"54","author":"Kwak","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2026.102908_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01206-17","article-title":"Systematic review and meta-analyses of the effect of chemotherapy on pulmonary Mycobacterium abscessus outcomes and disease recurrence","volume":"61","author":"Pasipanodya","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2026.102908_bib20","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1513\/AnnalsATS.202008-925OC","article-title":"Amikacin liposome inhalation suspension for Mycobacterium avium complex lung disease: a 12-month open-label extension clinical trial","volume":"18","author":"Winthrop","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jiac.2026.102908_bib21","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s40265-019-01095-z","article-title":"Amikacin liposome inhalation suspension: a review in Mycobacterium avium complex lung disease","volume":"79","author":"Shirley","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.jiac.2026.102908_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02349-19","article-title":"Synergistic activity of clofazimine and clarithromycin in an aerosol mouse model of Mycobacterium avium infection","volume":"64","author":"Lanoix","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2026.102908_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1100488","article-title":"Clofazimine for the treatment of tuberculosis","volume":"14","author":"Stadler","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jiac.2026.102908_bib24","doi-asserted-by":"crossref","first-page":"ofac194","DOI":"10.1093\/ofid\/ofac194","article-title":"Nebulized bacteriophage in a patient with refractory Mycobacterium abscessus lung disease","volume":"9","author":"Dedrick","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jiac.2026.102908_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/cid\/ciac453","article-title":"Phage therapy of mycobacterium infections: compassionate use of phages in 20 patients with drug-resistant mycobacterial disease","volume":"76","author":"Dedrick","year":"2023","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.jiac.2026.102908_bib26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2125.2000.00261.x","article-title":"Macrolide - induced clinically relevant drug interactions with cytochrome p-450a (cyp) 3a4: an update focused on clarithromycin, azithromycin and dirithromycin","volume":"50","author":"Westphal","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jiac.2026.102908_bib27","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1345\/aph.19138","article-title":"Macrolide drug interactions: an update","volume":"34","author":"Pai","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jiac.2026.102908_bib28","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.2165\/00003495-200464100-00005","article-title":"Qt prolongation with antimicrobial agents: understanding the significance","volume":"64","author":"Owens","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.jiac.2026.102908_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002280050714","article-title":"Qt-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience","volume":"56","author":"De Ponti","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jiac.2026.102908_bib30","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1177\/106002809502900913","article-title":"Macrolides versus azalides: a drug interaction update","volume":"29","author":"Amsden","year":"1995","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jiac.2026.102908_bib31","article-title":"Adverse events in people taking macrolide antibiotics versus placebo for any indication","volume":"1","author":"Hansen","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jiac.2026.102908_bib32","article-title":"Mitochondrial mutations in ethambutol-induced optic neuropathy","volume":"9","author":"Zhang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jiac.2026.102908_bib33","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/OPX.0000000000000783","article-title":"Ethambutol\/linezolid toxic optic neuropathy","volume":"93","author":"Libershteyn","year":"2016","journal-title":"Optom Vis Sci : official publication of the American Academy of Optometry"},{"key":"10.1016\/j.jiac.2026.102908_bib34","first-page":"4","article-title":"Ocular toxicity among patients taking anti-tubercular treatment","volume":"14","author":"Sitaula","year":"2022","journal-title":"Nepal J Ophthalmol : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH"},{"key":"10.1016\/j.jiac.2026.102908_bib35","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1038\/s41433-021-01663-2","article-title":"Visual electrophysiology in the assessment of toxicity and deficiency states affecting the visual system","volume":"35","author":"O'Neill","year":"2021","journal-title":"Eye"},{"key":"10.1016\/j.jiac.2026.102908_bib36","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.1128\/AAC.01124-13","article-title":"Induction of influx and efflux transporters and cytochrome p450 3a4 in primary human hepatocytes by rifampin, rifabutin, and rifapentine","volume":"57","author":"Williamson","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2026.102908_bib37","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/cts.13281","article-title":"A literature review of liver function test elevations in rifampin drug-drug interaction studies","volume":"15","author":"Ibrahim","year":"2022","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jiac.2026.102908_bib38","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1164\/rccm.200510-1666ST","article-title":"An official ats statement: hepatotoxicity of antituberculosis therapy","volume":"174","author":"Saukkonen","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2026.102908_bib39","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1177\/106002809502901114","article-title":"Rifabutin-associated uveitis","volume":"29","author":"Tseng","year":"1995","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jiac.2026.102908_bib40","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/937861","article-title":"Mechanisms of aminoglycoside ototoxicity and targets of hair cell protection","volume":"2011","author":"Huth","year":"2011","journal-title":"International journal of otolaryngology"},{"key":"10.1016\/j.jiac.2026.102908_bib41","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3389\/fncel.2017.00308","article-title":"Aminoglycoside-induced cochleotoxicity: a review","volume":"11","author":"Jiang","year":"2017","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.jiac.2026.102908_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22116109","article-title":"The mechanism of drug nephrotoxicity and the methods for preventing kidney damage","volume":"22","author":"Kwiatkowska","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jiac.2026.102908_bib43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40360-019-0302-1","article-title":"Safety and effectiveness of low-dose amikacin in nontuberculous mycobacterial pulmonary disease treated in toronto, Canada","volume":"20","author":"Aznar","year":"2019","journal-title":"BMC pharmacology & toxicology"},{"key":"10.1016\/j.jiac.2026.102908_bib44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2165\/00003495-200464010-00005","article-title":"The glycylcyclines: a comparative review with the tetracyclines","volume":"64","author":"Zhanel","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.jiac.2026.102908_bib45","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.3389\/fmicb.2019.01977","article-title":"Clinical efficacy and adverse effects of antibiotics used to treat Mycobacterium abscessus pulmonary disease","volume":"10","author":"Chen","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jiac.2026.102908_bib46","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41467-024-49797-7","article-title":"Structural basis for differential inhibition of eukaryotic ribosomes by tigecycline","volume":"15","author":"Li","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jiac.2026.102908_bib47","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1073\/pnas.1216691110","article-title":"Structural basis for potent inhibitory activity of the antibiotic tigecycline during protein synthesis","volume":"110","author":"Jenner","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jiac.2026.102908_bib48","article-title":"Clofazimine: a journey of a drug","volume":"167","author":"Xu","year":"2023","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.jiac.2026.102908_bib49","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/tmi.13977","article-title":"Clofazimine-induced cutaneous hyperpigmentation as a source of stigma in the treatment of leprosy: a cross-sectional study","volume":"29","author":"Nogueira","year":"2024","journal-title":"Trop Med Int Health : TM & IH"},{"key":"10.1016\/j.jiac.2026.102908_bib50","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw004","article-title":"Clofazimine enteropathy: a rare and underrecognized complication of mycobacterial therapy","volume":"3","author":"Szeto","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jiac.2026.102908_bib51","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1086\/501356","article-title":"Linezolid-induced inhibition of mitochondrial protein synthesis","volume":"42","author":"De Vriese","year":"2006","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.jiac.2026.102908_bib52","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4046\/trd.2021.0122","article-title":"Concise clinical review of hematologic toxicity of linezolid in multidrug-resistant and extensively drug-resistant tuberculosis: role of mitochondria","volume":"85","author":"Oehadian","year":"2022","journal-title":"Tuberc Respir Dis"},{"key":"10.1016\/j.jiac.2026.102908_bib53","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4103\/meajo.MEAJO_73_20","article-title":"Linezolid-induced toxic optic neuropathy","volume":"27","author":"Aljebreen","year":"2020","journal-title":"Middle East Afr J Ophthalmol"},{"key":"10.1016\/j.jiac.2026.102908_bib54","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12941-023-00655-2","article-title":"Effectiveness and safety of regimens containing linezolid for treatment of Mycobacterium abscessus pulmonary disease","volume":"22","author":"Cheng","year":"2023","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.jiac.2026.102908_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/ph18020184","article-title":"Fluoroquinolone-mediated tendinopathy and tendon rupture","volume":"18","author":"Duman","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jiac.2026.102908_bib56","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010077","article-title":"Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study","volume":"5","author":"Daneman","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.jiac.2026.102908_bib57","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000334441","article-title":"Qt prolongation and torsade de pointes induced by fluoroquinolones: infrequent side effects from commonly used medications","volume":"120","author":"Briasoulis","year":"2011","journal-title":"Cardiology"},{"key":"10.1016\/j.jiac.2026.102908_bib58","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ijantimicag.2006.11.011","article-title":"Arrhythmias associated with fluoroquinolone therapy","volume":"29","author":"Falagas","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2026.102908_bib59","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s40264-013-0089-8","article-title":"Tendon injury and fluoroquinolone use: a systematic review","volume":"36","author":"Stephenson","year":"2013","journal-title":"Drug Saf"},{"key":"10.1016\/j.jiac.2026.102908_bib60","article-title":"Oral fluoroquinolone use and serious arrhythmia: Bi-national cohort study","volume":"352","author":"Inghammar","year":"2016","journal-title":"Br Med J"},{"key":"10.1016\/j.jiac.2026.102908_bib61","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2165\/11587280-000000000-00000","article-title":"Quinolones: Review of psychiatric and neurological adverse reactions","volume":"34","author":"Tome","year":"2011","journal-title":"Drug Saf"},{"key":"10.1016\/j.jiac.2026.102908_bib62","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4103\/ijmy.ijmy_159_18","article-title":"Ursodeoxycholic acid attenuates hepatotoxicity of multidrug treatment of mycobacterial infections: a prospective pilot study","volume":"8","author":"Lang","year":"2019","journal-title":"International journal of mycobacteriology"},{"key":"10.1016\/j.jiac.2026.102908_bib63","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s12906-015-0861-7","article-title":"A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury","volume":"15","author":"Luangchosiri","year":"2015","journal-title":"BMC Compl Alternative Med"},{"key":"10.1016\/j.jiac.2026.102908_bib64","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3192351","article-title":"Prophylactic therapy of silymarin (milk thistle) on antituberculosis drug-induced liver injury: a meta-analysis of randomized controlled trials","volume":"2019","author":"Tao","year":"2019","journal-title":"Canadian journal of gastroenterology & hepatology"},{"key":"10.1016\/j.jiac.2026.102908_bib65","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1097\/MEG.0b013e32833aa11b","article-title":"Protective effect of n-acetylcysteine on antituberculosis drug-induced hepatotoxicity","volume":"22","author":"Baniasadi","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jiac.2026.102908_bib66","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1513\/AnnalsATS.202406-626OC","article-title":"Intermittent versus daily therapy for noncavitary Mycobacterium avium complex pulmonary disease: an open-label randomized trial","volume":"22","author":"Nakagawa","year":"2025","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jiac.2026.102908_bib67","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3389\/fncel.2017.00325","article-title":"Towards the prevention of aminoglycoside-related hearing loss","volume":"11","author":"O'Sullivan","year":"2017","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.jiac.2026.102908_bib68","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0378-5955(98)00195-6","article-title":"Attenuation of aminoglycoside-induced cochlear damage with the metabolic antioxidant alpha-lipoic acid","volume":"128","author":"Conlon","year":"1999","journal-title":"Hear Res"},{"key":"10.1016\/j.jiac.2026.102908_bib69","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/sj.ki.5002295","article-title":"Gentamicin-induced ototoxicity in hemodialysis patients is ameliorated by n-acetylcysteine","volume":"72","author":"Feldman","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.jiac.2026.102908_bib70","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1525-1497.2005.30323.x","article-title":"N-acetylcysteine for the prevention of contrast-induced nephropathy. A systematic review and meta-analysis","volume":"20","author":"Liu","year":"2005","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jiac.2026.102908_bib71","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMc053428","article-title":"Aspirin to prevent gentamicin-induced hearing loss","volume":"354","author":"Sha","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2026.102908_bib72","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.heares.2006.05.008","article-title":"Aspirin attenuates gentamicin ototoxicity: from the laboratory to the clinic","volume":"226","author":"Chen","year":"2007","journal-title":"Hear Res"},{"key":"10.1016\/j.jiac.2026.102908_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.908584","article-title":"A case report and literature review of the outcome of linezolid-induced optic and peripheral neuropathy in patients with multidrug-resistant pulmonary tb","volume":"13","author":"Bano","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.jiac.2026.102908_bib74","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1183\/09031936.00169114","article-title":"The tolerability of linezolid in the treatment of nontuberculous mycobacterial disease","volume":"45","author":"Winthrop","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2026.102908_bib75","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01178-20","article-title":"Preserved efficacy and reduced toxicity with intermittent linezolid dosing in combination with bedaquiline and pretomanid in a murine tuberculosis model","volume":"64","author":"Bigelow","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2026.102908_bib76","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/jac\/dkh405","article-title":"Reversal of linezolid-associated cytopenias, but not peripheral neuropathy, by administration of vitamin b6","volume":"54","author":"Spellberg","year":"2004","journal-title":"The Journal of antimicrobial chemotherapy"},{"key":"10.1016\/j.jiac.2026.102908_bib77","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1086\/508280","article-title":"No effect of pyridoxine on the incidence of myelosuppression during prolonged linezolid treatment","volume":"43","author":"Plachouras","year":"2006","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.jiac.2026.102908_bib78","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1164\/rccm.200407-863OC","article-title":"Ethambutol ocular toxicity in treatment regimens for Mycobacterium avium complex lung disease","volume":"172","author":"Griffith","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2026.102908_bib79","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.resinv.2021.06.010","article-title":"Lower dose of ethambutol may reduce ocular toxicity without radiological deterioration for Mycobacterium avium complex pulmonary disease","volume":"59","author":"Ando","year":"2021","journal-title":"Respiratory investigation"},{"key":"10.1016\/j.jiac.2026.102908_bib80","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2023-255383","article-title":"Pulmonary Mycobacterium abscessus infection treated in combination with inhaled tigecycline","volume":"16","author":"Pedersen","year":"2023","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jiac.2026.102908_bib81","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.rmed.2019.10.006","article-title":"Efficacy and safety of tigecycline for Mycobacterium abscessus disease","volume":"158","author":"Kwon","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.jiac.2026.102908_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2023.102306","article-title":"Spray dried tigecycline dry powder aerosols for the treatment of nontuberculous mycobacterial pulmonary infections","volume":"139","author":"Maloney","year":"2023","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jiac.2026.102908_bib83","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1473-2165.2005.00151.x","article-title":"Relevance of vitamins c and e in cutaneous photoprotection","volume":"4","author":"Eberlein-Konig","year":"2005","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.jiac.2026.102908_bib84","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.2169\/internalmedicine.4498-24","article-title":"Quantifying the reversibility of clofazimine-induced pigmentation in a patient with Mycobacterium abscessus pulmonary disease","volume":"64","author":"Ito","year":"2025","journal-title":"Intern Med"},{"key":"10.1016\/j.jiac.2026.102908_bib85","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1517\/14740338.1.2.121","article-title":"Cardiotoxicity of macrolides, ketolides and fluoroquinolones that prolong the qtc interval","volume":"1","author":"Iannini","year":"2002","journal-title":"Expet Opin Drug Saf"},{"key":"10.1016\/j.jiac.2026.102908_bib86","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1161\/CIR.0000000000000905","article-title":"Drug-induced arrhythmias: a scientific statement from the american heart association","volume":"142","author":"Tisdale","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jiac.2026.102908_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens14040302","article-title":"N-acetylcysteine as a host-directed therapy against clarithromycin-resistant Mycobacterium abscessus","volume":"14","author":"Yang","year":"2025","journal-title":"Pathogens"},{"key":"10.1016\/j.jiac.2026.102908_bib88","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02166-24","article-title":"Effective killing of Mycobacterium abscessus biofilm by nanoemulsion delivery of plant phytochemicals","volume":"13","author":"Albano","year":"2025","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jiac.2026.102908_bib89","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.micpath.2017.02.030","article-title":"N-acetylcysteine inhibits growth, adhesion and biofilm formation of gram-positive skin pathogens","volume":"105","author":"Eroshenko","year":"2017","journal-title":"Microb Pathog"},{"key":"10.1016\/j.jiac.2026.102908_bib90","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s40262-021-01000-6","article-title":"Therapeutic drug monitoring in non-tuberculosis mycobacteria infections","volume":"60","author":"Alffenaar","year":"2021","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jiac.2026.102908_bib91","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/jac\/dku062","article-title":"Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections","volume":"69","author":"Wallace","year":"2014","journal-title":"The Journal of antimicrobial chemotherapy"},{"key":"10.1016\/j.jiac.2026.102908_bib92","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1086\/420742","article-title":"Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases","volume":"38","author":"Peloquin","year":"2004","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.jiac.2026.102908_bib93","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jgar.2020.01.004","article-title":"Discontinuation rates attributed to adverse events and treatment outcomes between clarithromycin and azithromycin in Mycobacterium avium complex lung disease: a propensity score analysis","volume":"22","author":"Kwon","year":"2020","journal-title":"Journal of global antimicrobial resistance"},{"key":"10.1016\/j.jiac.2026.102908_bib94","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/ICU.0000000000000416","article-title":"Ethambutol optic neuropathy","volume":"28","author":"Chamberlain","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jiac.2026.102908_bib95","doi-asserted-by":"crossref","DOI":"10.3389\/fopht.2023.1152215","article-title":"Incidence, risk factors and ophthalmic clinical characteristic of ethambutol-induced optic neuropathy: 7-year experience","volume":"3","author":"Chaitanuwong","year":"2023","journal-title":"Frontiers in ophthalmology"},{"key":"10.1016\/j.jiac.2026.102908_bib96","doi-asserted-by":"crossref","first-page":"e256","DOI":"10.1093\/cid\/ciaa1361","article-title":"Management of drug toxicity in Mycobacterium avium complex pulmonary disease: an expert panel survey","volume":"73","author":"van Ingen","year":"2021","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.jiac.2026.102908_bib97","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1186\/s12879-023-08815-7","article-title":"Clinical efficacy and safety of tigecycline based on therapeutic drug monitoring for carbapenem-resistant gram-negative bacterium pneumonia in intensive care units","volume":"23","author":"Bai","year":"2023","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiac.2026.102908_bib98","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofx147","article-title":"Clofazimine in nontuberculous mycobacterial infections: a growing niche","volume":"4","author":"McGuffin","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jiac.2026.102908_bib99","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.2147\/IDR.S365371","article-title":"Linezolid-associated neuropathy in patients with mdr\/xdr tuberculosis in shenzhen, China","volume":"15","author":"Zhang","year":"2022","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jiac.2026.102908_bib100","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/cid\/ciab699","article-title":"Proposed linezolid dosing strategies to minimize adverse events for treatment of extensively drug-resistant tuberculosis","volume":"74","author":"Imperial","year":"2022","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.jiac.2026.102908_bib101","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1080\/14740338.2018.1520837","article-title":"Moxifloxacin-induced qt interval prolongation and torsades de pointes: a narrative review","volume":"17","author":"Khan","year":"2018","journal-title":"Expet Opin Drug Saf"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26000061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26000061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:11:23Z","timestamp":1778800283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X26000061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":101,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1341321X26000061"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2026.102908","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjunctive and supportive strategies to mitigate drug toxicities in the treatment of nontuberculous mycobacterial disease with future directions","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2026.102908","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102908"}}